WALLEYE CAPITAL LLC – Revance Therapeutics, Inc. Transaction History
WALLEYE CAPITAL LLC portfolio value:
$14.12M
portfolio value
WALLEYE CAPITAL LLC quarter portfolio value change:
+95.37%
quarter
Revance Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +12.49% | 58.07K shares | 7.69M | $27 | 523.04K |
| Q2 2022 | share | Decrease | -8.05% | -40.73K shares | -3.43M | $13.82 | 464.97K |
| Q1 2022 | share | Increase | +41.56% | 148.46K shares | 4.03M | $19.5 | 505.70K |
| Q4 2021 | share | Increase | +555.76% | 302.76K shares | 4.31M | $16.49 | 357.23K |
| Q3 2021 | share | Decrease | -49.02% | -52.38K shares | -1.64M | $27.86 | 54.47K |
| Q2 2021 | share | Increase | +52.11% | 36.61K shares | 1.20M | $29.64 | 106.85K |
| Q1 2021 | share | Decrease | -1.56% | -1.11K shares | -59K | $27.95 | 70.24K |
| Q4 2020 | share | Increase | 0.00% | 71.36K shares | 2.02M | $28.34 | 71.36K |
| Q3 2019 | call | Decrease | -100.00% | -28K shares | -363K | $13 | 0 |
| Q3 2019 | put | Decrease | -100.00% | -6.3K shares | -82K | $13 | 0 |
| Q2 2019 | put | Increase | 0.00% | 6.3K shares | 82K | $12.97 | 6.3K |
| Q2 2019 | call | Increase | 0.00% | 28K shares | 363K | $12.97 | 28K |
| Q1 2019 | share | Decrease | -100.00% | -17.64K shares | -438K | $15.76 | 0 |
| Q3 2018 | share | Increase | 0.00% | 17.64K shares | 438K | $24.85 | 17.64K |